Namayandeh M, Jafarabadi Z, Azadi S. The Use of Population Attributable Risk to Estimate The Impact of Preventive Interventions of Smoking Cessation in Chronic Obstructive Pulmonary Disease(COPD). JCHR 2020; 9 (4) :213-214
URL:
http://jhr.ssu.ac.ir/article-1-684-en.html
1- 1. Research Center of Prevention and Epidemiology of Non-Communicable Disease, Department of statistics and Epidemiology, School of public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran 2. Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- 2. Research Center of Prevention and Epidemiology of Non-Communicable Disease, Department of statistics and Epidemiology, School of public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , jafarabadi14@gmail.com
3- 3. Research Center of Prevention and Epidemiology of Non-Communicable Disease, Department of statistics and Epidemiology, School of public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract: (2374 Views)
Chronic pulmonary disorders are a set of diseases that restrict respiration airflow(1).Most of these diseases are chronic obstructive pulmonary disease (COPD)(1). According to the WHO report, mortality from COPD is increasing worldwide. It is expected to be the third leading cause of death worldwide by 2030(2) (the sixth leading cause of death in 1990(3). This disease causes significant costs for health systems(4). There is strong evidence between COPD and smoking as a major risk factor. Smoking cessation is the most effective measure to prevent or slow COPD progression (2,5).
The effect of smoking on COPD was assessed in selected studies using the odds ratio (OR). The data analysis results using the random effects method showed that the risk of COPD was higher in smokers and those exposed to cigarette smoke.(current smoker; 95% CI: 0.78 – 4.31, OR: 1.83, Ex-smoker; CI: 1.05 - 4.98, OR: 2.29, passive smoker; CI: 0.43_3.08 , OR: 1.15)(3,6).
According to the results of the 7th national survey of non-communicable disease risk factors (Steps 2016),the distribution of current smokers, ex-smokers, and passive smokers were 9.71, 14.63,and 31.53 among over 18 years old, respectively(7). Furthermore, the population attributed risk (PAR) of each factor with Levin formula (PAR=P(OR-1)/P(OR-1)+1) is 0.89%, 0.95%, and 82.5%, respectively, which indicates when smoking would eradicate in populations, we can propose to lower up to almost 90 % in the population’s COPD.
Review:
Letter to The Editor |
Subject:
Epidemiology Received: 2020/09/21 | Accepted: 2020/12/20 | Published: 2020/12/26
References
1. 1. Barnes PJ, Burney PG, Silverman EK, et al. Chronic Obstructive Pulmonary Disease. Nature Reviews Disease Primers. 2015;1:15076. [
DOI:10.1038/nrdp.2015.76]
2. Morjaria JB, Mondati E, Polosa R.E-Cigarettes in Patients with COPD: Current Perspectives. International Journal of Chronic Obstructive Pulmonary Disease. 2017;12:3203-10. [
DOI:10.2147/COPD.S135323]
3. Sharifi H, Masjedi MR, Emami H, et al. Burden of Obstructive Lung Disease Study in Tehran: Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease. Lung India: Official Organ of Indian Chest Society. 2015;32(6):572-7. [
DOI:10.4103/0970-2113.168129]
4. Ur Rehman A, Ahmad Hassali MA, Muhammad SA, et al. The Economic Burden of Chronic Obstructive Pulmonary Disease (COPD) in The USA, Europe, and Asia: Results from A Systematic Review of The Literature. Expert Review of Pharmacoeconomics & Outcomes Research. 2020; 20(6): 661-72. [
DOI:10.1080/14737167.2020.1678385]
5. Bai JW, Chen XX, Liu S, et al. Smoking Cessation Affects The Natural History of COPD. International Journal of Chronic Obstructive Pulmonary Disease. 2017;12:3323-8. [
DOI:10.2147/COPD.S150243]
6. Golshan M, Amra B, Welte T. Sample Survey of Chronic Obstructive Pulmonary Disease and Associated Risk Factors in Isfahan,Iran. Tanaffos. 2011;10(3):32-6.
7. Ministry of Health and Medical Education . National Non Communicable Diseases Surveillance Survey: NCDSS (STEPs 2016). Tehran: National Institute for Health Research Islamic Repulic of IRAN. 2016. Available from: https://nih.tums.ac.ir/UpFiles/Documents/34d5ee8d-864e-46df-be72-83de3178f833.pdf
8. P T, . Smoking cessation and COPD. European respiratory review : an official journal of the European Respiratory Society. 2013;22(127):37-43. [
DOI:10.1183/09059180.00007212]
9. Jordan CJ, Xi ZX. Discovery and development of varenicline for smoking cessation. Expert opinion on drug discovery. 2018;13(7):671-83. [
DOI:10.1080/17460441.2018.1458090]